These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34705621)

  • 1. Asporin Promotes TGF-β-induced Lung Myofibroblast Differentiation by Facilitating Rab11-Dependent Recycling of TβRI.
    Huang S; Lai X; Yang L; Ye F; Huang C; Qiu Y; Lin S; Pu L; Wang Z; Huang W
    Am J Respir Cell Mol Biol; 2022 Feb; 66(2):158-170. PubMed ID: 34705621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nestin promotes pulmonary fibrosis
    Wang J; Lai X; Yao S; Chen H; Cai J; Luo Y; Wang Y; Qiu Y; Huang Y; Wei X; Wang B; Lu Q; Guan Y; Wang T; Li S; Xiang AP
    Eur Respir J; 2022 May; 59(5):. PubMed ID: 34625478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating rutin as a potential transforming growth factor-β type I receptor antagonist for the inhibition of bleomycin-induced lung fibrosis.
    Karunarathne WAHM; Lee KT; Choi YH; Kang CH; Lee MH; Kim SH; Kim GY
    Biofactors; 2024; 50(3):477-492. PubMed ID: 38006284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of OGN in lung myofibroblasts attenuates pulmonary fibrosis by inhibiting integrin αv-mediated TGF-β/Smad pathway activation.
    Huang S; Lin Y; Deng Q; Zhang Y; Peng S; Qiu Y; Huang W; Wang Z; Lai X
    Matrix Biol; 2024 Sep; 132():87-97. PubMed ID: 39019241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathway.
    Fang L; Chen H; Kong R; Que J
    Life Sci; 2020 Nov; 260():118399. PubMed ID: 32918977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.
    Guo X; Adeyanju O; Sunil C; Mandlem V; Olajuyin A; Huang S; Chen SY; Idell S; Tucker TA; Qian G
    Am J Physiol Cell Physiol; 2022 Jul; 323(1):C133-C144. PubMed ID: 35584329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
    J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.
    Rahaman SO; Grove LM; Paruchuri S; Southern BD; Abraham S; Niese KA; Scheraga RG; Ghosh S; Thodeti CK; Zhang DX; Moran MM; Schilling WP; Tschumperlin DJ; Olman MA
    J Clin Invest; 2014 Dec; 124(12):5225-38. PubMed ID: 25365224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transforming growth factor-beta type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis.
    Zhao Y; Shah DU
    Exp Mol Pathol; 2000 Oct; 69(2):67-78. PubMed ID: 11001857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albendazole ameliorates aerobic glycolysis in myofibroblasts to reverse pulmonary fibrosis.
    Zeng C; Yue H; Wang C; Ju X; Wang T; Fu X; Zhou Q; Zhang H; He L; Yu J; Wang Y
    J Transl Med; 2024 Oct; 22(1):910. PubMed ID: 39375691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin enhances multi-walled carbon nanotube-triggered lung fibrosis by promoting TGF-β1 activation and myofibroblast differentiation.
    Dong J; Ma Q
    Part Fibre Toxicol; 2017 Jun; 14(1):18. PubMed ID: 28595626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
    Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
    Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.